HopeStage
Back to all studies
CompletedNCT03034408

Nalmefene and Baclofen Effects on Impulsivity in Alcohol Use

About this title

Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects

Read the official source — NCT03034408
Medication studyAges 18+SwitzerlandAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
GenevaSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJuly 1, 2016
Recruitment status
Completed
Enrollment listed in the registry
37
Sponsor
Prof. Daniele Zullino
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Switzerland
Age range
Over 18 Years
Official registry ID
NCT03034408
Official title
Show the full official title

Effects of Nalmefene and Baclofen on Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects: A Randomized, Placebo-controlled Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Geneva

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Prof. Daniele Zullino.

Did this study involve medication?

Yes. The study involved medication, including Nalmefene, Baclofen and Placebo Oral Capsule.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies